Novartis Can't Apply NJ Punitives Cap In 3 Zometa Suits

Law360, New York (November 26, 2013, 1:54 PM EST) -- Pennsylvania product liability law permitting unlimited punitive damages controls three suits alleging Novartis Pharmaceuticals Corp.’s bone drug Zometa caused jaw injuries, a federal judge said Friday, denying the drugmaker’s attempt to apply softer New Jersey law.

U.S. District Judge Mark. R. Hornak applied Pennsylvania law to the suits despite arguments from Novartis that New Jersey, home to its U.S. headquarters, bore the more significant relationship to the punitive damages issue as the site of the alleged corporate misconduct.

The ruling effectively removes a punitive-damages cap of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

ROWLAND v. NOVARTIS PHARMACEUTICALS CORPORATION


Case Number

2:12-cv-01474

Court

Pennsylvania Western

Nature of Suit

Personal Inj. Prod. Liability

Judge

Mark R. Hornak

Date Filed

October 11, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.